# Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)

> **NCT00305630** · PHASE2,PHASE3 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 100 (—)

## Conditions studied

- Choroidal Neovascularization
- Age-Related Macular Degeneration

## Interventions

- **DRUG:** Periocular injection of triamcinolone acetonide 40mg

## Key facts

- **NCT ID:** NCT00305630
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 100 (—)
- **Last updated:** 2006-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00305630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00305630, "Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00305630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*